ETF Series Solutions - Range Cancer Therapeutics ETF Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

What is the ownership structure of E18B?
Owner Type	Number of Shares	Ownership Percentage
Institutions	163,296	100.0%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 17 shareholders own 0% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0%	Susquehanna International Group, LLP, Asset Management Arm	39,359	€0	168.28%	no data
0%	Royal Bank of Canada, Banking & Securities Investments	31,753	€0	73.04%	no data
0%	Vontobel Asset Management, Inc.	25,827	€0	0%	no data
0%	The Colony Group, LLC	18,933	€0	0%	no data
0%	LPL Financial Corporation, Asset Management Arm	15,664	€0	-9.35%	no data
0%	Private Advisor Group, LLC	10,355	€0	-20.07%	no data
0%	Prospera Financial Services, Asset Management Arm	10,000	€0	0%	no data
0%	Morgan Stanley, Investment Banking and Brokerage Investments	3,512	€0	-13%	no data
0%	Advisor Group Holdings, Inc., Asset Management Arm	2,985	€0	-9.13%	no data
0%	UBS Asset Management AG	1,899	€0	-31.32%	no data
0%	Blue Bell Private Wealth Management, LLC	1,708	€0	0.06%	no data
0%	Coastal Investment Advisors, Inc.	539	€0	0%	no data
0%	Securities America Advisors, Inc.	500	€0	0%	no data
0%	SOA Wealth Advisors, LLC	150	€0	0%	no data
0%	RBC Dominion Securities Inc., Asset Management Arm	65	€0	0%	no data
0%	Baldrige Asset Management, LLC	37	€0	0%	no data
0%	NewEdge Advisors, LLC	10	€0	0%	no data